Matches in SemOpenAlex for { <https://semopenalex.org/work/W2021926852> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W2021926852 endingPage "2020" @default.
- W2021926852 startingPage "2016" @default.
- W2021926852 abstract "Background Patients newly diagnosed with type 2 diabetes mellitus generally initiate therapy with either metformin [Met] or a sulfonylurea [SU] drug, followed by the addition of a second agent (Met, an SU drug, or a thiazolidinedione [TZD] drug) if the diabetes is not well controlled. If necessary, the usual third line of treatment is the addition of insulin. Objective The purpose of our study was to compare the progression to insulin among 3 cohorts receiving the oral antidiabetic (OAD) drug combinations Met/SU, Met/TZD, or SU/TZD. Methods This study used data from the Texas Medicaid database. The date of addition of a second OAD was considered a patient's index date and patients were followed for up to 5 years. Cox proportional hazards regression compared the progression to first insulin use among cohorts, using the Met/SU cohort as the reference group, while adjusting for demographics, comorbidities, and propensity scores. Results A total of 4083 patients were included in the study (Met/SU = 2872, Met/TZD = 438, and SU/TZD = 773). Insulin was added to the medication regimen of patients by the end of follow-up in 19.7% of the Met/SU cohort, 17.6% of the Met/TZD cohort, and 26.3% of the SU/TZD cohort. The adjusted Cox proportional model estimated that patients in the SU/TZD cohort had a 40% higher probability of progression to insulin than patients in the Met/SU cohort (odds ratio [OR] = 1.40; 95% CI, 1.19–1.64), whereas there was no significant difference between the Met/TZD and Met/SU cohorts (OR = 0.85; 95% CI, 0.67–1.08). Conclusions It appears that mechanism of action may play a role in progression to insulin for concomitant OAD agents. A slower progression to insulin was seen for patients receiving a paired sensitizer regimen (ie, Met/TZD) compared with those receiving a secretagogue sensitizer regimen (ie, SU/TZD)." @default.
- W2021926852 created "2016-06-24" @default.
- W2021926852 creator A5016989520 @default.
- W2021926852 creator A5026604545 @default.
- W2021926852 creator A5037714580 @default.
- W2021926852 creator A5060004548 @default.
- W2021926852 creator A5089504354 @default.
- W2021926852 date "2011-12-01" @default.
- W2021926852 modified "2023-10-18" @default.
- W2021926852 title "Progression to Insulin for Patients with Diabetes Mellitus Using the Texas Medicaid Database" @default.
- W2021926852 cites W1980847604 @default.
- W2021926852 cites W2022503712 @default.
- W2021926852 cites W2042353763 @default.
- W2021926852 cites W2058982800 @default.
- W2021926852 cites W2060837253 @default.
- W2021926852 cites W2072642789 @default.
- W2021926852 cites W2074132105 @default.
- W2021926852 cites W2097112828 @default.
- W2021926852 cites W2163498104 @default.
- W2021926852 cites W2752336761 @default.
- W2021926852 doi "https://doi.org/10.1016/j.clinthera.2011.10.018" @default.
- W2021926852 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22101160" @default.
- W2021926852 hasPublicationYear "2011" @default.
- W2021926852 type Work @default.
- W2021926852 sameAs 2021926852 @default.
- W2021926852 citedByCount "7" @default.
- W2021926852 countsByYear W20219268522012 @default.
- W2021926852 countsByYear W20219268522013 @default.
- W2021926852 countsByYear W20219268522015 @default.
- W2021926852 countsByYear W20219268522016 @default.
- W2021926852 countsByYear W20219268522020 @default.
- W2021926852 crossrefType "journal-article" @default.
- W2021926852 hasAuthorship W2021926852A5016989520 @default.
- W2021926852 hasAuthorship W2021926852A5026604545 @default.
- W2021926852 hasAuthorship W2021926852A5037714580 @default.
- W2021926852 hasAuthorship W2021926852A5060004548 @default.
- W2021926852 hasAuthorship W2021926852A5089504354 @default.
- W2021926852 hasConcept C126322002 @default.
- W2021926852 hasConcept C134018914 @default.
- W2021926852 hasConcept C201903717 @default.
- W2021926852 hasConcept C207103383 @default.
- W2021926852 hasConcept C2779306644 @default.
- W2021926852 hasConcept C2780323712 @default.
- W2021926852 hasConcept C2781413609 @default.
- W2021926852 hasConcept C44249647 @default.
- W2021926852 hasConcept C50382708 @default.
- W2021926852 hasConcept C555293320 @default.
- W2021926852 hasConcept C71924100 @default.
- W2021926852 hasConcept C72563966 @default.
- W2021926852 hasConceptScore W2021926852C126322002 @default.
- W2021926852 hasConceptScore W2021926852C134018914 @default.
- W2021926852 hasConceptScore W2021926852C201903717 @default.
- W2021926852 hasConceptScore W2021926852C207103383 @default.
- W2021926852 hasConceptScore W2021926852C2779306644 @default.
- W2021926852 hasConceptScore W2021926852C2780323712 @default.
- W2021926852 hasConceptScore W2021926852C2781413609 @default.
- W2021926852 hasConceptScore W2021926852C44249647 @default.
- W2021926852 hasConceptScore W2021926852C50382708 @default.
- W2021926852 hasConceptScore W2021926852C555293320 @default.
- W2021926852 hasConceptScore W2021926852C71924100 @default.
- W2021926852 hasConceptScore W2021926852C72563966 @default.
- W2021926852 hasIssue "12" @default.
- W2021926852 hasLocation W20219268521 @default.
- W2021926852 hasLocation W20219268522 @default.
- W2021926852 hasOpenAccess W2021926852 @default.
- W2021926852 hasPrimaryLocation W20219268521 @default.
- W2021926852 hasRelatedWork W1978360972 @default.
- W2021926852 hasRelatedWork W1996010611 @default.
- W2021926852 hasRelatedWork W2084730744 @default.
- W2021926852 hasRelatedWork W2158701418 @default.
- W2021926852 hasRelatedWork W2521415133 @default.
- W2021926852 hasRelatedWork W2528919078 @default.
- W2021926852 hasRelatedWork W2978227646 @default.
- W2021926852 hasRelatedWork W3010794336 @default.
- W2021926852 hasRelatedWork W3110151069 @default.
- W2021926852 hasRelatedWork W4229452352 @default.
- W2021926852 hasVolume "33" @default.
- W2021926852 isParatext "false" @default.
- W2021926852 isRetracted "false" @default.
- W2021926852 magId "2021926852" @default.
- W2021926852 workType "article" @default.